Therefore, we aimed to investigate the association between the targeted proteomics of CSF samples with the Aβ42/Aβ40 ratio, ADAS-cog-13, and ADAS-total in AD and non-AD groups. This evidence concerns the gene AGPS and Alzheimer disease.